NIH shares data on Alzheimer's biomarkers

The NIH is sharing data from a proteomics study launched to identify new plasma-based biomarkers for Alzheimer's disease. The study, the first in a multi-phase program, was undertaken by a team of experts drawn from academia, industry and the government. Story

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.